Strong tuberculin response after BCG vaccination is associated with low multiple sclerosis risk: a population-based cohort study.

A strong in vivo vaccine response to BCG is associated with reduced MS risk >30 years later. The immunological mechanisms determining TST reactivity suggest that skewed T-cell-mediated immunity precedes MS onset by many decades.